1-10 of 10
Feda Azab, B.Pharm
Close
Sort by
Journal Articles

3D Tissue-Engineered Bone Marrow Cultures Induce Drug Resistance, De-Differentiation and Cytokine Expression Changes in Multiple Myeloma

Pilar De La Puente, PhD, Barbara Muz, PhDMSc, Feda Azab, B.Pharm, Justin King, Ravi Vij, MD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2014) 124 (21): 2069.
https://doi.org/10.1182/blood.V124.21.2069.2069
Published: 2014
Journal Articles

A Novel and Personalized Method Using Simulation for Predicting Effective Therapeutics for Waldenströms Macroglobulinemia

Abdel Kareem Azab, BPharm, PhD, Aneel Paulus, MDMS, Feda Azab, B.Pharm, Sharoon Akhtar, MPhil, Shireen Vali, PhD, Ansu Kumar, Neeraj Kumar Singh, Shweta Kapoor, Taher Abbasi, MS, Asher Chanan-Khan, MD, Kasyapa S. Chitta, PhD
Journal: Blood
Blood (2014) 124 (21): 3024.
https://doi.org/10.1182/blood.V124.21.3024.3024
Published: 2014
Journal Articles

PYK2 Inhibitors Sensitize Hypoxia-Induced Drug Resistant Multiple Myeloma Cell

Barbara Muz, PhDMSc, Maurizio Buggio, PhD MSc, Feda Azab, B.Pharm, Anthony F. Trombino, PhD, Mahesh Padval, PhD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2014) 124 (21): 4704.
https://doi.org/10.1182/blood.V124.21.4704.4704
Published: 2014
Journal Articles

Patient-Derived 3D Tissue-Engineered Bone Marrow Cultures Support Primary MM Growth

Pilar De La Puente, PhD, Feda Azab, B.Pharm, Barbara Muz, PhDMSc, Justin King, Ravi Vij, MD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2014) 124 (21): 4705.
https://doi.org/10.1182/blood.V124.21.4705.4705
Published: 2014
Journal Articles

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitors

Barbara Muz, PhDMSc, Feda Azab, B.Pharm, Pilar De La Puente, PhD, Scott A Rollins, PhD, Richard Alvarez, MBA, Ziad Kawar, PhD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2014) 124 (21): 4758.
https://doi.org/10.1182/blood.V124.21.4758.4758
Published: 2014
Journal Articles

CD138-Independent Strategy for Detecting Residual and Circulating Myeloma Plasma Cells

Barbara Muz, PhDMSc, Feda Azab, B.Pharm, de la Puente Pilar, PhD MSc, Jacob Paasch, BS, Justin King, Luderer Micah, Ravi Vij, MBBS, MD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2014) 124 (21): 2077.
https://doi.org/10.1182/blood.V124.21.2077.2077
Published: 2014
Journal Articles

PI3K-Alpha Plays A Major Role In Multiple Myeloma and Its Inhibition With BYL917 Decreases Proliferation, Synergizes With Other Therapies and Overcomes Stroma-Induced Resistance

Feda Azab, B.Pharm, Shireen Vali, Nicholas Potter, Joseph Abraham, Barbara Muz, PhD, MSc, Pilar De La Puente, PhD, Taher Abbasi, Ravi Vij, MD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2013) 122 (21): 3215.
https://doi.org/10.1182/blood.V122.21.3215.3215
Published: 2013
Journal Articles

Tumor Hypoxia Promotes Dissemination and Tumor Colonization In Waldenström Macroglobulinemia

Barbara Muz, PhD, MSc, Feda Azab, B.Pharm, Pilar De La Puente, PhD, Ravi Vij, MD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2013) 122 (21): 3011.
https://doi.org/10.1182/blood.V122.21.3011.3011
Published: 2013
Journal Articles

Hypoxia Induces Drug Resistance In Multiple Myeloma

Barbara Muz, PhD, MSc, Feda Azab, B.Pharm, Pilar De La Puente, PhD, Irene M. Ghobrial, MD, Ravi Vij, MD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2013) 122 (21): 1852.
https://doi.org/10.1182/blood.V122.21.1852.1852
Published: 2013
Journal Articles

Autologous 3D Tissue-Engineered Bone Marrow For Drug Screening In MM Patients

Pilar De La Puente, PhD, Feda Azab, B.Pharm, Barbara Muz, PhD, MSc, Ravi Vij, MD, Abdel Kareem Azab, BPharm, PhD
Journal: Blood
Blood (2013) 122 (21): 132.
https://doi.org/10.1182/blood.V122.21.132.132
Published: 2013